All sites C00-96,D32-33,D42-43,D45-47,D76 1462 89.3 3.9 3.6 1.0 2.2
Mouth, pharynx C00-14 48 99.6 - - - 0.4
  Lip C00 2 100.0 - - - -
  Tongue C02 8 100.0 - - - -
  Mouth, other C03-06 13 100.0 - - - -
  Salivary glands C07-08 2 100.0 - - - -
  Pharynx C01,C09-14 23 99.1 - - - 0.9
Digestive organs C15-26 288 82.6 4.1 8.1 1.6 3.7
  Oesophagus C15 23 91.3 0.9 5.2 0.9 1.7
  Stomach C16 24 94.2 0.8 0.8 0.8 3.3
  Small intestine C17 5 100.0 - - - -
  Colon C18 77 97.9 0.3 1.8 - -
  Rectum, rectosigmoid C19-20 48 97.1 - 0.4 0.8 1.7
  Anus C21 4 100.0 - - - -
  Liver C22 39 65.6 3.1 22.1 4.1 5.1
  Gallbladder, bile ducts C23-24 9 65.2 15.2 10.9 4.3 4.3
  Pancreas C25 54 53.9 15.5 18.1 3.3 9.2
  Other digestive organs C26 4 42.1 5.3 21.1 - 31.6
Respiratory organs C30-39 180 66.4 15.3 10.8 3.3 4.2
  Nose, sinuses C30-31 2 100.0 - - - -
  Larynx, epiglottis C32 13 98.5 - - 1.5 -
  Lung, trachea C33-34 162 63.3 16.8 11.6 3.6 4.7
  Mediastinum, pleura C38 2 62.5 - 37.5 - -
Bone C40-41 3 100.0 - - - -
Melanoma of the skin C43 81 99.8 0.2 - - -
Skin, non-melanoma C44 73 99.7 0.3 - - -
Mesothelioma C45 11 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 10 96.2 - 1.9 - 1.9
Breast C50 3 100.0 - - - -
Male genital organs C60-63 420 99.0 - 0.1 0.2 0.6
  Prostate C61 395 99.0 - 0.1 0.3 0.7
  Testis C62 22 100.0 - - - -
  Other male genital C60,C63 3 100.0 - - - -
Urinary organs C64-68 125 93.3 1.3 3.0 0.6 1.8
  Kidney C64 49 87.8 1.2 6.9 0.8 3.3
  Bladder and urinary tract2 C65-68 76 96.8 1.3 0.5 0.5 0.8
Eye C69 2 87.5 - 12.5 - -
Brain, central nervous system C70-72,D32-33,D42-43 47 96.2 - 2.5 - 1.3
Thyroid gland C73 12 94.8 5.2 - - -
Other endocrine glands C74-75 2 90.9 - - - 9.1
Illdefined or unknown C76,C80 20 59.4 15.8 14.9 4.0 5.9
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 136 84.2 8.5 1.0 1.2 5.1
  Hodgkin lymphoma C81 11 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 60 99.0 1.0 - - -
  Malignant immunoproliferative diseases C88 2 100.0 - - - -
  Myeloma and other plasma cell tumors C90 16 80.2 9.9 2.5 4.9 2.5
  Leukaemia C91-95 32 67.9 22.2 0.6 1.2 8.0
  Myelodysplastic syndromes D46 4 26.3 26.3 - 5.3 42.1
  Myeloproliferaitive neoplasms D45,D47 11 58.9 10.7 7.1 1.8 21.4
Not included above
  Basal cell carcinoma of the skin 465 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.